The bank upgraded the fast casual Mexican chain to overweight from equal weight.
This drugmaker is developing breakthroughs like an ‘EpiPen for heart attacks.’ The market has yet to give it credit
The key to its growth are a non-opioid pain reliever, a potential blockbuster lupus treatment and a drug that has been dubbed an “EpiPen for heart attacks.”
Confirmed screwworm case in Texas sends two biotech stocks higher
Options volume is surging for Zoetis as traders look for potential stock market winners in light of a screwworm case in Texas.
Broadcom sparks a chip stock sell-off. Is this the start of a bigger turn?
Signs pointed to this move being more about about taking profits off extreme highs than moderating AI demand.
This industrial giant continues to reach new heights. The charts suggest more gains lie ahead
Jay Woods of Freedom Capital Markets takes a look at the short and long-term technicals of this industrial name.
Ark Invest owns SpaceX in its venture ETF. It says Starlink alone supports $2 trillion value at IPO
Brett Winton said SpaceX’s Starlink satellite broadband network is the primary driver of ARK’s valuation thesis.
Barclays traders say it’s time to buy protection for a tech-led S&P 500 pullback
The stock market rally could be in trouble here as tech falters, and traders at Barclays think investors should protect themselves.
Investors can ‘buy’ SpaceX early with Coinbase perpetual futures on pre-IPOs
Pre-IPO perps give traders the ability to speculate on the value of a private company without owning shares.
This healthcare giant should see shares rise on successful strategy shift, Bank of America says
UnitedHealth’s efforts to cut costs and simplify its business are beginning to boost its bottom line, which should push up shares, per Bank of America.
Here are Thursday’s biggest analyst calls: Nvidia, Apple, Broadcom, Netflix, Oracle, Microsoft, CrowdStrike & more
Here are Thursday’s biggest calls on Wall Street.